Neuropeptide Y (NPY) is widely distributed throughout sympathetic nerve endings where it
is co‐stored and co‐secreted with noradrenaline. It is considered a marker of noradrenergic …

Patients with pituitary tumours often present with disabling headache but there is no clear
relationship between tumour size and headache. Neuropeptide Y (NPY) has been identified …

The demonstration in preclinical studies that centrally administered neuropeptide Y (NPY)
has anxiolytic effects had led to speculation that NPY may play a role in human anxiety …

The high concentration of the tyrosine-rich polypeptide, neuropeptide Y (NPY), and the
increase in the number of its receptor subtypes that have been characterized in the brain …

Neuropeptide Y (NPY) was first discovered and characterized as a 36‐amino‐acid peptide
neurotransmitter in 1982. It is widely distributed in the central nervous system, with …

Neuropeptide Y (NYP) is a 36 amino acid peptide which shares considerable sequence
homology with pancreatic polypeptide and peptide YY. NPY is widely distributed within …

2. Materials and methods All experiments were conducted under a license of the University
of California, San Francisco Institutional Animal Care and Use Committee (IACUC) and …

Introduction: Neuropeptide Y (NPY) is a highly conserved neuropeptide belonging to the
pancreatic polypeptide family. Its potential role in the etiology and pathophysiology of mood …

Background Neuropeptide Y (NPY) has been implicated in the modulation of pain. Under
normal conditions, NPY is found in interneurons in the dorsal horn of the spinal cord and in …

Neuropeptide Y (NPY) is one of the most abundant peptide in the brain and has been
implicated in various biological functions. Pre-clinical and clinical investigations have …